Lead Exposure, Genetics, and Osteoporosis Epidemiology

This study has been completed.

First Received on March 26, 2001. Last Updated on September 1, 2006 History of Changes

Sponsor:	National Institute of Environmental Health Sciences (NIEHS)
Information provided by:	National Institute of Environmental Health Sciences (NIEHS)
ClinicalTrials.gov Identifier:	NCT00013637

Purpose

This study's primary objective is to assess the effects of environmental lead exposures and genetic risk factors on the development of osteoporosis in middle-aged women.

Condition
Osteoporosis

Study Type:	Observational
Study Design:	Observational Model: Defined Population Observational Model: Natural History Time Perspective: Longitudinal Time Perspective: Prospective

Resource links provided by NLM:

Genetics Home Reference related topics: Help Me Understand Genetics

MedlinePlus related topics: Osteoporosis

U.S. FDA Resources

Further study details as provided by National Institute of Environmental Health Sciences (NIEHS):

Estimated Enrollment:	650
Study Start Date:	September 1998
Estimated Study Completion Date:	August 2003

Eligibility

Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Healthy participants in the Nurses' Health Study who live in the greater Boston metropolitan area.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00013637

Locations

United States, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115

Sponsors and Collaborators

National Institute of Environmental Health Sciences (NIEHS)

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00013637 History of Changes
Other Study ID Numbers:	8074-CP-001
Study First Received:	March 26, 2001
Last Updated:	September 1, 2006
Health Authority:	United States: Federal Government

Keywords provided by National Institute of Environmental Health Sciences (NIEHS):

Osteoporosis
Lead

Additional relevant MeSH terms:

Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on February 12, 2012